ESC 2012 Roundtable Discussions
20 September 2012
| Article by Excerpta Medica
ESC 2012 Roundtable Discussions
At the ESC congress in Munich, Germany, in August 2012, Philips sponsored a series of specialist-led roundtable discussions about some of the important clinical issues in cardiology and imaging.
These discussions provided an interactive platform for the exchange of opinions and experiences between leading cardiologists and physicians about some of the important current issues in cardiology. The roundtable sessions were led by key opinion leaders and attracted an enthusiastic audience of conference delegates from around the world.
PDF: ESC Roundtable: Cardiology Leadership Dialogs
At the recent ESC congress in Munich, Philips sponsored a series of specialist-led roundtable discussions about some of the important clinical issues in cardiology and imaging. A short highlights report is now available for you to download.
Video: Which innovations in imaging may take transcatheter treatment of valve disease to the next level?
During ESC 2012, Dr J. Balzer of the Universitätsklinikum Düsseldorf, Germany, led two roundtable discussions entitled ‘Which innovations in imaging may take transcatheter treatment of valve disease to the next level?’ These Global discussion sessions attracted participants from many countries including the UK, Columbia, France, Belgium, Brazil, Portugal, and the USA who discussed the challenges to the further development of transcatheter treatment of valve disease and innovations that are likely to overcome those challenges.
Video: Establishing an AF network
Stroke and chest pain networks around the world have been shown to lead to improved patient outcomes and greater cost-effectiveness of diagnosis and patient management. But how useful would a network be for the management of atrial fibrillation (AF)? This question was addressed during a global roundtable discussion at the ESC 2012, led by Dr L. Dekker of the Catherina Ziekenhuis Eindhoven, in the Netherlands.
Video: STEMI and NSTEMI diagnosis and treatment. How can we improve further?
During ESC 2012, Professor B. Lindahl of Uppsala Clinical Research Center, Uppsala, Sweden, and Professor J. Mair of the Medizinische Universitaet Innsbruck, Innsbruck, Austria, led global roundtable discussions on the diagnosis and treatment of ST-elevation myocardial infarction (STEMI) and non-ST-elevation myocardial infarction (NSTEMI). These truly global discussions drew enthusiastic participants from all corners of the world, including Romania, Saudi Arabia, Abu Dabi, India, Brazil, Sweden, UK, Oman, USA, and Germany. The central question that participants were asked to consider was: How can the diagnosis and treatment of STEMI and NSTEMI be improved further?
Video: How can we safeguard operator safety while performing more complex interventional cases?
At the ESC 2012 conference, Professor N. Reifart led a global roundtable discussion entitled ‘How can we safeguard operator safety while performing more complex interventional cases?’ The roundtable participants from the USA, UK, Netherlands, Germany, and Greece, including interventional radiologists and cardiologists, were encouraged to describe their own experiences in attempting to minimize the dangers from stochastic radiation exposure during their daily practice.
Video: How integrated cardiac care centers can improve the quality and efficiency of care
This roundtable session at the ESC was intended to focus on integrated cardiac care centers, however the roundtable leader, Professor J.L. Zamorano of the University Clinic San Carlos, Madrid, Spain, initiated the discussion by emphasizing that he would like there to be a free exchange of views on any matters concerning quality and efficiency of cardiac care. With participants from many countries including Brazil, Russia, Australia, USA, France, Germany, and the Netherlands, many discussions concerned comparisons between healthcare systems and reimbursement issues around the world.
Back to ESC 2012 Coverage
This content has been made possible by GetInsideHealth
Share this on:
Rate this article
MetS, T2DM, and the risk of biventricular dysfunction
Type 2 diabetes (T2DM) is recognized as a strong predictor of heart failure (HF), regardless of the presence of other cardiovascular risk factors. The annual incidence of HF in the diabetic population ranges from 14 to 31 out of every 1000 individuals per year, and the reported relative risk varies from...
21 February 2013
by Hypertension Research 2013
cMRI for assessing left atrial catheter ablation lesions
Although catheter ablation is now a recognized treatment for those with symptomatic atrial fibrillation (AF) refractory to drug therapy,1 a significant proportion require repeat procedures.2 Recurrences of AF are usually associated with pulmonary vein (PV) reconnection, where tissue injured by catheter...
19 February 2013
by Journal of Cardiovascular Electrophysiology 2013